Sugiaman-Trapman, Debora
Vitezic, Morana
Jouhilahti, Eeva-Mari
Mathelier, Anthony
Lauter, Gilbert
Misra, Sougat
Daub, Carsten O.
Kere, Juha
Swoboda, Peter http://orcid.org/0000-0001-6416-8572
Funding for this research was provided by:
Royal Swedish Academy of Sciences
Hjärnfonden
Torsten Söderbergs Stiftelse
Åhlén-stiftelsen
Karolinska Institutet (KID funding, Distinguished Professor Award, Strategic Neurosciences Program)
Horizon 2020 (EU Horizon 2020 Marie Curie Individual Fellowship)
Genome Canada Large Scale Applied Research Grant (174CDE)
BC Children’s Hospital Foundation
Radiumhospitalets Forskningsstifltelse
Helse Sør-Øst RHF
Svenska Sällskapet för Medicinsk Forskning
Stiftelsen Lars Hiertas Minne
Fredrik och Ingrid Thurings Stiftelse
Royal Society Wolfson Research Excellence Award
Article History
Received: 3 November 2017
Accepted: 21 February 2018
First Online: 6 March 2018
Ethics approval and consent to participate
: For work with mammalian cell cultures the authors are in possession of the applicable permits for carrying out studies with genetically modified micro-organisms / GMMs (Dnr 5.8.18–1012/14; Dnr 5.5.18–6998/15).
: This section is not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.